Advertisement
Letter to the Editor| Volume 7, ISSUE 6, P919-921, November 2014

Download started.

Ok

Safe Management of a Bipolar Depressed Patient With Prefrontal Repetitive Transcranial Magnetic Stimulation (rTMS) Over 7 Years and >2 Million Stimuli

Published:October 07, 2014DOI:https://doi.org/10.1016/j.brs.2014.09.005
      Daily left prefrontal rTMS is being increasingly used for the acute treatment of unipolar and bipolar depression, with acute remission rates in open-label studies ranging from 30 to 60% [
      • George M.S.
      • Lisanby S.H.
      • Avery D.
      • et al.
      Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial.
      ,
      • Carpenter L.L.
      • Janicak P.G.
      • Aaronson S.T.
      • et al.
      Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice.
      ]. The treatment also appears to have reasonable 6 and 12-month durability [
      • Janicak P.G.
      • Nahas Z.
      • Lisanby S.H.
      • et al.
      Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study.
      ,
      • Mantovani A.
      • Pavlicova M.
      • Avery D.
      • et al.
      Long-term efficacy of repeated daily prefrontal transcranial magnetic stimulation (TMS) in treatment-resistant depression.
      ]. However, some patients require periodic maintenance treatments in order to not relapse back into a complete episode [
      • Li X.
      • Nahas Z.
      • Anderson B.
      • Kozel F.A.
      • George M.S.
      Can left prefrontal rTMS be used as a maintenance treatment for bipolar depression?.
      ]. There is much discussion but little data concerning the safety of long-term maintenance TMS, or how much exposure to TMS an individual can have over a lifetime [
      • Rossi S.
      • Hallett M.
      • Rossini P.M.
      • Pascual-Leone A.
      Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research.
      ]. We present the case of a young woman who may have the highest TMS exposure to date (7 years, 2 million stimuli), who is largely depression free without safety issues.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      References

        • George M.S.
        • Lisanby S.H.
        • Avery D.
        • et al.
        Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial.
        Arch Gen Psychiatry. 2010; 67: 507-516
        • Carpenter L.L.
        • Janicak P.G.
        • Aaronson S.T.
        • et al.
        Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice.
        Depress Anxiety. 2012; 29: 587-596
        • Janicak P.G.
        • Nahas Z.
        • Lisanby S.H.
        • et al.
        Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study.
        Brain Stimul. 2010; 3: 187-199
        • Mantovani A.
        • Pavlicova M.
        • Avery D.
        • et al.
        Long-term efficacy of repeated daily prefrontal transcranial magnetic stimulation (TMS) in treatment-resistant depression.
        Depress Anxiety. 2012; 29: 883-890
        • Li X.
        • Nahas Z.
        • Anderson B.
        • Kozel F.A.
        • George M.S.
        Can left prefrontal rTMS be used as a maintenance treatment for bipolar depression?.
        Depress Anxiety. 2004; 20: 98-100
        • Rossi S.
        • Hallett M.
        • Rossini P.M.
        • Pascual-Leone A.
        Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research.
        Clin Neurophysiol. 2009; 120: 2008-2039
        • Hadley D.
        • Anderson B.S.
        • Borckardt J.J.
        • et al.
        Safety, tolerability, and effectiveness of high doses of adjunctive daily left prefrontal repetitive transcranial magnetic stimulation for treatment-resistant depression in a clinical setting.
        J ECT. 2011; 27: 18-25